chr9-2622134-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003383.5(VLDLR):​c.-56C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.357 in 1,441,502 control chromosomes in the GnomAD database, including 95,885 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8164 hom., cov: 30)
Exomes 𝑓: 0.36 ( 87721 hom. )

Consequence

VLDLR
NM_003383.5 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.127
Variant links:
Genes affected
VLDLR (HGNC:12698): (very low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. This gene encodes a lipoprotein receptor that is a member of the LDLR family and plays important roles in VLDL-triglyceride metabolism and the reelin signaling pathway. Mutations in this gene cause VLDLR-associated cerebellar hypoplasia. Alternative splicing generates multiple transcript variants encoding distinct isoforms for this gene. [provided by RefSeq, Aug 2009]
VLDLR-AS1 (HGNC:49621): (VLDLR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.47).
BP6
Variant 9-2622134-C-T is Benign according to our data. Variant chr9-2622134-C-T is described in ClinVar as [Benign]. Clinvar id is 366354.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.409 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
VLDLRNM_003383.5 linkuse as main transcriptc.-56C>T 5_prime_UTR_variant 1/19 ENST00000382100.8
VLDLR-AS1NR_015375.2 linkuse as main transcriptn.240G>A non_coding_transcript_exon_variant 1/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
VLDLRENST00000382100.8 linkuse as main transcriptc.-56C>T 5_prime_UTR_variant 1/191 NM_003383.5 P98155-1
VLDLR-AS1ENST00000657742.1 linkuse as main transcriptn.240G>A non_coding_transcript_exon_variant 1/10

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
46792
AN:
147390
Hom.:
8166
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.149
Gnomad AMI
AF:
0.217
Gnomad AMR
AF:
0.409
Gnomad ASJ
AF:
0.283
Gnomad EAS
AF:
0.424
Gnomad SAS
AF:
0.252
Gnomad FIN
AF:
0.369
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.392
Gnomad OTH
AF:
0.325
GnomAD4 exome
AF:
0.362
AC:
468011
AN:
1294016
Hom.:
87721
Cov.:
22
AF XY:
0.357
AC XY:
226931
AN XY:
636032
show subpopulations
Gnomad4 AFR exome
AF:
0.138
Gnomad4 AMR exome
AF:
0.397
Gnomad4 ASJ exome
AF:
0.271
Gnomad4 EAS exome
AF:
0.405
Gnomad4 SAS exome
AF:
0.225
Gnomad4 FIN exome
AF:
0.365
Gnomad4 NFE exome
AF:
0.378
Gnomad4 OTH exome
AF:
0.337
GnomAD4 genome
AF:
0.317
AC:
46805
AN:
147486
Hom.:
8164
Cov.:
30
AF XY:
0.318
AC XY:
22879
AN XY:
71926
show subpopulations
Gnomad4 AFR
AF:
0.149
Gnomad4 AMR
AF:
0.409
Gnomad4 ASJ
AF:
0.283
Gnomad4 EAS
AF:
0.424
Gnomad4 SAS
AF:
0.252
Gnomad4 FIN
AF:
0.369
Gnomad4 NFE
AF:
0.392
Gnomad4 OTH
AF:
0.328
Alfa
AF:
0.343
Hom.:
4759
Bravo
AF:
0.311

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxJun 26, 2018- -
Congenital cerebellar hypoplasia Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJun 14, 2016- -
Cerebellar ataxia, intellectual disability, and dysequilibrium syndrome 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.47
CADD
Benign
17
DANN
Benign
0.97

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34881325; hg19: chr9-2622134; COSMIC: COSV66073719; COSMIC: COSV66073719; API